Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
45
MD Quote, Financials, Valuation and Earnings
Last price:
$13.59
Seasonality move
:
-0.34%
Day range:
$13.49 - $13.72
52-week range:
$6.62 - $16.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.57x
P/B ratio:
1.61x
Volume:
204.4K
Avg. volume:
818.9K
1-year change:
43.71%
Market cap:
$1.2B
Revenue:
$2B
EPS (TTM):
-$3.06
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group
|
$498.8M | $0.37 | -1.89% | 41.39% | -- |
|
CON
Concentra Group Holdings Parent
|
$492.6M | $0.36 | 4.64% | -15.2% | $29.69 |
|
EHC
Encompass Health
|
$1.3B | $0.94 | 10.79% | 19.79% | -- |
|
KDLY
Kindly MD
|
-- | -- | -- | -- | -- |
|
TOI
The Oncology Institute
|
$103.3M | -$0.10 | 27.72% | -52.63% | -- |
|
USPH
US Physical Therapy
|
$164.4M | $0.68 | 11.02% | 78.95% | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group
|
$13.71 | -- | $1.2B | -- | $0.00 | 0% | 0.57x |
|
CON
Concentra Group Holdings Parent
|
$20.48 | $29.69 | $2.6B | 23.59x | $0.06 | 0.31% | 1.37x |
|
EHC
Encompass Health
|
$94.17 | -- | $9.5B | 22.75x | $0.17 | 0.66% | 1.84x |
|
KDLY
Kindly MD
|
$1.06 | -- | $6.3M | -- | $0.00 | 0% | 2.10x |
|
TOI
The Oncology Institute
|
$0.22 | -- | $16.9M | -- | $0.00 | 0% | 0.04x |
|
USPH
US Physical Therapy
|
$90.26 | -- | $1.4B | 53.09x | $0.44 | 1.95% | 2.10x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MD
Pediatrix Medical Group
|
46.11% | 1.033 | 62.98% | 1.36x |
|
CON
Concentra Group Holdings Parent
|
100% | 0.000 | 51.63% | 1.37x |
|
EHC
Encompass Health
|
56.81% | 0.137 | 24.53% | 0.81x |
|
KDLY
Kindly MD
|
5.14% | 0.000 | 3% | 5.08x |
|
TOI
The Oncology Institute
|
85.53% | -0.897 | 370.59% | 2.19x |
|
USPH
US Physical Therapy
|
22.79% | 2.474 | 9.74% | 1.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group
|
$116.8M | $52.4M | -17.29% | -30.86% | 6.92% | $85.5M |
|
CON
Concentra Group Holdings Parent
|
$138.5M | $86.2M | 10.76% | 14.17% | 17.61% | $50.8M |
|
EHC
Encompass Health
|
$1.3B | $209.1M | 8.26% | 17.39% | 16.19% | $120.3M |
|
KDLY
Kindly MD
|
$640.1K | -$1M | -137.75% | -201.03% | -155.05% | -$1M |
|
TOI
The Oncology Institute
|
$14.4M | -$13.9M | -53.47% | -163.45% | -13.9% | $1.2M |
|
USPH
US Physical Therapy
|
$29.1M | $14.7M | 1.37% | 1.67% | 8.54% | $19.6M |
Pediatrix Medical Group vs. Competitors
-
Which has Higher Returns MD or CON?
Concentra Group Holdings Parent has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of 9.06%. Pediatrix Medical Group's return on equity of -30.86% beat Concentra Group Holdings Parent's return on equity of 14.17%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group22.85% $0.23 $1.4B CONConcentra Group Holdings Parent28.29% $0.37 $1.5B -
What do Analysts Say About MD or CON?
Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.27%. On the other hand Concentra Group Holdings Parent has an analysts' consensus of $29.69 which suggests that it could grow by 34.28%. Given that Concentra Group Holdings Parent has higher upside potential than Pediatrix Medical Group, analysts believe Concentra Group Holdings Parent is more attractive than Pediatrix Medical Group.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group0 0 0 CONConcentra Group Holdings Parent5 0 0 -
Is MD or CON More Risky?
Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison Concentra Group Holdings Parent has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MD or CON?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Concentra Group Holdings Parent offers a yield of 0.31% to investors and pays a quarterly dividend of $0.06 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. Concentra Group Holdings Parent pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MD or CON?
Pediatrix Medical Group quarterly revenues are $511.2M, which are larger than Concentra Group Holdings Parent quarterly revenues of $489.6M. Pediatrix Medical Group's net income of $19.4M is lower than Concentra Group Holdings Parent's net income of $44.3M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while Concentra Group Holdings Parent's PE ratio is 23.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 1.37x for Concentra Group Holdings Parent. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.57x -- $511.2M $19.4M CONConcentra Group Holdings Parent1.37x 23.59x $489.6M $44.3M
-
Which has Higher Returns MD or EHC?
Encompass Health has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of 8.01%. Pediatrix Medical Group's return on equity of -30.86% beat Encompass Health's return on equity of 17.39%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group22.85% $0.23 $1.4B EHCEncompass Health95.51% $1.06 $5.3B -
What do Analysts Say About MD or EHC?
Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.27%. On the other hand Encompass Health has an analysts' consensus of -- which suggests that it could grow by 23.71%. Given that Encompass Health has higher upside potential than Pediatrix Medical Group, analysts believe Encompass Health is more attractive than Pediatrix Medical Group.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group0 0 0 EHCEncompass Health0 0 0 -
Is MD or EHC More Risky?
Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison Encompass Health has a beta of 0.876, suggesting its less volatile than the S&P 500 by 12.393%.
-
Which is a Better Dividend Stock MD or EHC?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health offers a yield of 0.66% to investors and pays a quarterly dividend of $0.17 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. Encompass Health pays out 17.16% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MD or EHC?
Pediatrix Medical Group quarterly revenues are $511.2M, which are smaller than Encompass Health quarterly revenues of $1.4B. Pediatrix Medical Group's net income of $19.4M is lower than Encompass Health's net income of $108.2M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while Encompass Health's PE ratio is 22.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 1.84x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.57x -- $511.2M $19.4M EHCEncompass Health1.84x 22.75x $1.4B $108.2M
-
Which has Higher Returns MD or KDLY?
Kindly MD has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of -156.54%. Pediatrix Medical Group's return on equity of -30.86% beat Kindly MD's return on equity of -201.03%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group22.85% $0.23 $1.4B KDLYKindly MD98.8% -$0.17 $3.7M -
What do Analysts Say About MD or KDLY?
Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.27%. On the other hand Kindly MD has an analysts' consensus of -- which suggests that it could fall by --. Given that Pediatrix Medical Group has higher upside potential than Kindly MD, analysts believe Pediatrix Medical Group is more attractive than Kindly MD.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group0 0 0 KDLYKindly MD0 0 0 -
Is MD or KDLY More Risky?
Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison Kindly MD has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MD or KDLY?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kindly MD offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. Kindly MD pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MD or KDLY?
Pediatrix Medical Group quarterly revenues are $511.2M, which are larger than Kindly MD quarterly revenues of $647.9K. Pediatrix Medical Group's net income of $19.4M is higher than Kindly MD's net income of -$1M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while Kindly MD's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 2.10x for Kindly MD. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.57x -- $511.2M $19.4M KDLYKindly MD2.10x -- $647.9K -$1M
-
Which has Higher Returns MD or TOI?
The Oncology Institute has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of -16.13%. Pediatrix Medical Group's return on equity of -30.86% beat The Oncology Institute's return on equity of -163.45%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group22.85% $0.23 $1.4B TOIThe Oncology Institute14.38% -$0.18 $107M -
What do Analysts Say About MD or TOI?
Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.27%. On the other hand The Oncology Institute has an analysts' consensus of -- which suggests that it could grow by 795.26%. Given that The Oncology Institute has higher upside potential than Pediatrix Medical Group, analysts believe The Oncology Institute is more attractive than Pediatrix Medical Group.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group0 0 0 TOIThe Oncology Institute0 0 0 -
Is MD or TOI More Risky?
Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MD or TOI?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MD or TOI?
Pediatrix Medical Group quarterly revenues are $511.2M, which are larger than The Oncology Institute quarterly revenues of $99.9M. Pediatrix Medical Group's net income of $19.4M is higher than The Oncology Institute's net income of -$16.1M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 0.04x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.57x -- $511.2M $19.4M TOIThe Oncology Institute0.04x -- $99.9M -$16.1M
-
Which has Higher Returns MD or USPH?
US Physical Therapy has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of 3.29%. Pediatrix Medical Group's return on equity of -30.86% beat US Physical Therapy's return on equity of 1.67%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group22.85% $0.23 $1.4B USPHUS Physical Therapy17.34% $0.39 $813.2M -
What do Analysts Say About MD or USPH?
Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.27%. On the other hand US Physical Therapy has an analysts' consensus of -- which suggests that it could grow by 23.35%. Given that US Physical Therapy has higher upside potential than Pediatrix Medical Group, analysts believe US Physical Therapy is more attractive than Pediatrix Medical Group.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group0 0 0 USPHUS Physical Therapy0 0 0 -
Is MD or USPH More Risky?
Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison US Physical Therapy has a beta of 1.463, suggesting its more volatile than the S&P 500 by 46.285%.
-
Which is a Better Dividend Stock MD or USPH?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. US Physical Therapy offers a yield of 1.95% to investors and pays a quarterly dividend of $0.44 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. US Physical Therapy pays out 164.43% of its earnings as a dividend.
-
Which has Better Financial Ratios MD or USPH?
Pediatrix Medical Group quarterly revenues are $511.2M, which are larger than US Physical Therapy quarterly revenues of $168M. Pediatrix Medical Group's net income of $19.4M is higher than US Physical Therapy's net income of $5.5M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while US Physical Therapy's PE ratio is 53.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 2.10x for US Physical Therapy. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.57x -- $511.2M $19.4M USPHUS Physical Therapy2.10x 53.09x $168M $5.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 26
Power Solutions International [PSIX] is down 0.73% over the past day.
Buy
65
TSLL alert for Dec 26
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 2.97% over the past day.
Buy
75
SMLR alert for Dec 26
Semler Scientific [SMLR] is down 1.67% over the past day.
